Hematology/Oncology · Rio Piedras, PR
NPI
1104010651
Since 2007
Specialty
Hematology/Oncology
Code 261QX0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
369 Ave Jose de Diego, Torre San Francisco Oficina 603
Rio Piedras, PR, 00923
Phone (787) 753-6022
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,577
1,013 services
Medicare patients, 2024
30
Average age 77
Drug cost, 2024
$3.3M
1,225 prescriptions
Company payments, 2025
$6,313
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pedro G Solivan Ortiz was code 99213 (office e&m - established), 72 times for 24 patients. In total Pedro G Solivan Ortiz billed 1,013 services in 16 codes, and Medicare paid $8,577.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 72 | 24 | $63.62 | $4,581 |
By year: 2022 $22K for 397 services; 2023 $28K for 1,228 services; 2024 $8,577 for 1,013 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pedro G Solivan Ortiz prescribed most often to Medicare patients was Anastrozole, with 249 prescriptions and refills. In total Pedro G Solivan Ortiz wrote 1,225 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 249 | 347 | 48 | $4,485 |
| Dexamethasone Generic | 118 | 118 | 29 | $1,706 |
| Famotidine Generic | 71 | 83 | 37 | $478 |
| Ondansetron Hcl Generic | 48 | 48 | 30 | $565 |
| Letrozole Generic | 41 | 49 | Under 11 | $673 |
| Revlimid Lenalidomide | 38 | 38 | Under 11 | $632K |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $590K |
| Retacrit Epoetin Alfa-Epbx | 31 | 31 | 16 | $54K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 31 | 31 | 13 | $678 |
| Gabapentin Generic | 28 | 32 | 11 | $232 |
| Prednisone Generic | 22 | 22 | Under 11 | $92.25 |
| Xarelto Rivaroxaban | 21 | 21 | Under 11 | $12K |
| Eliquis Apixaban | 20 | 20 | Under 11 | $12K |
| Pregabalin Generic | 16 | 16 | Under 11 | $141 |
| Sprycel Dasatinib | 16 | 16 | Under 11 | $287K |
Brand drugs: 307 claims; generic drugs: 918 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pedro G Solivan Ortiz $6,313 ($6,313 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $2,325.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $2,325 |
| AstraZeneca Pharmaceuticals LP AZN | 30 | $770 |
| Janssen Pharmaceuticals, Inc JNJ | 27 | $621 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $336 |
| Merck Sharp & Dohme LLC MRK | 12 | $255 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $198 |
| Genentech USA, Inc. ROG.SW | 8 | $181 |
| Tempus AI, Inc TEM | 8 | $176 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $174 |
| Amgen Inc. AMGN | 7 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.